Discover the top five most accurate Wall Street analysts and their latest stock picks, along with their ratings accuracy, price targets, and recent news updates. Get valuable insights from experts like William Stein, Aaron Rakers, Sidney Ho, Alex Rygiel, and Harsh Kumar.
In a recent episode of CNBC’s ‘Mad Money Lightning Round,’ Jim Cramer shared his thoughts on several stocks, including Ally Financial, Snowflake, Royalty Pharma, and Core Scientific. Cramer recommended buying Ally Financial but was hesitant on Snowflake due to recent downgrades. He expressed disappointment with Royalty Pharma’s performance and labeled Core Scientific as overvalued.
Based on the Old Faithful Geyser, which erupts regularly in Yellowstone National Park, this stock screening method identifies companies with strong financial performance and growth potential. Five selected stocks for the coming year include Lennar (homebuilding), Agco (agricultural equipment), Hibbett (sporting goods), Farmers & Merchants Bancorp (community banking), and Arrow Electronics (electronic parts distribution). Over the past 21 years, this screening method has yielded an average 12-month return of 20.5%, outperforming the S&P 500 Total Return Index.
CNBC’s ‘Mad Money’ host Jim Cramer analyzed several stocks on his show, including Upstart Holdings, ARS Pharmaceuticals, SMART Global Holdings, Enbridge, and Medtronic.
